-
Study aim
-
Determining and comparing the diagnostic accuracy of endometrial sampling with endometrial biopsy catheter produced by Health Engineering Company yar Hakim and dilatation and curettage
-
Design
-
In this study, 60 patients in the age range of 18-75 years who refer to endometrial tissue sampling for various reasons will be selected based on continuous sampling method and after obtaining informed consent will be examined.
Due to the fact that patients are first biopsied from the endometrium by a court biopsy and then need general anesthesia, dilatation and curettage, in fact, these patients are selected as a control group to examine the endometrium with a curette, there is no need to match the age, cause of bleeding and delivery rank. These patients will be included in the study non-randomly after obtaining consent.
-
Settings and conduct
-
For sampling with a pipette, by suction of the syringe and pulling the end of the catheter tube, which has side holes, the excised tissue is inserted into the catheter. Then D&C is performed with cervical dilatation. Both samples obtained with a pipette and D&C are examined by a pathologist as a single blind.
-
Participants/Inclusion and exclusion criteria
-
The patient will be examined in the age range of 18-75 years after obtaining informed consent. Women with a history of endometrial cancer, atypical endometrial hyperplasia, a positive pregnancy test result, or unwillingness to participate are excluded from the study.
-
Intervention groups
-
Control group:
Including 60 patients, dilatation and curettage operation will be performed for endometrial biopsy.
Intervention group:
Including 60 patients, endometrial biopsy catheter will be used for endometrial sampling, a product of Salamat yar Hakim Engineering Company.
-
Main outcome variables
-
Pathological outcome, patients' pain intensity, complications after biopsy